As reported, about two weeks post-implant of the bard/davol ventralex mesh, the patient was diagnosed with mild surrounding erythema which resolved with no treatment required.The clinician has assessed the patient¿s postoperative course as being ¿possibly¿ related to the study device and definitely related to the procedure, however, based on the information provided, no conclusion can be made.
|
Reported per clinical trial (b)(6): on (b)(6) 2019 - the subject patient underwent primary open midline periumbilical hernia repair procedure during which a bard/davol ventralex hernia patch was placed and sutured with non-bard/davol (pds) suture.Full skin closure was achieved with staples.The patient was discharged to home on (b)(6) 2019.On (b)(6) 2019 - subject patient was diagnosed with mild surrounding erythema.No action taken.Per the study clinician, the reported adverse event has been assessed as mild in severity, possibly related to the study device and definitely related to the index procedure.The outcome for this ae is reported as recovered/resolved.
|